Literature DB >> 19589823

WHO researchers start trial on a new drug for river blindness.

Nayanah Siva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19589823     DOI： 10.1136/bmj.b2755

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Comparative evaluation of systemic drugs for their effects against Anopheles gambiae.

Authors:  Matthew P Butters; Kevin C Kobylinski; Kelsey M Deus; Ines Marques da Silva; Meg Gray; Massamba Sylla; Brian D Foy
Journal:  Acta Trop       Date:  2011-10-14       Impact factor: 3.112

2.  An improved ivermectin-activated chloride channel receptor for inhibiting electrical activity in defined neuronal populations.

Authors:  Timothy Lynagh; Joseph W Lynch
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

3.  Ocular onchocerciasis: current management and future prospects.

Authors:  Olufemi Emmanuel Babalola
Journal:  Clin Ophthalmol       Date:  2011-10-13

4.  Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity.

Authors:  Cécile Ménez; Jean-François Sutra; Roger Prichard; Anne Lespine
Journal:  PLoS Negl Trop Dis       Date:  2012-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.